Coherus BioSciences Inc. (Coherus) is a late-stage clinical biologics platform Company. The Company is focused on delivering biosimilar therapeutics. Biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The Company has worked on approximately 100 molecules, developed and manufactured around 14 products and launched approximately 30 products across the world. Coherus� is in partnerships include global pharmaceutical companies in Europe, Asia and Latin America.